Amneal 製藥公司
US ˙ NasdaqGS ˙ US03168L1052

SecurityAMRX / Amneal Pharmaceuticals, Inc.
InstitutionLindbrook Capital, Llc
Latest Disclosed Ownership511 shares
Latest Disclosed Value $ 4,282
Lindbrook Capital, Llc ownership in AMRX / Amneal Pharmaceuticals, Inc.

On May 5, 2025 - Lindbrook Capital, Llc filed a 13F-HR form disclosing ownership of 511 shares of Amneal Pharmaceuticals, Inc. (US:AMRX) valued at $4,282 USD as of March 31, 2025. The entity filed a previous 13F-HR on February 6, 2025 disclosing 511 shares of Amneal Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $7,026 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-05-05 2025-03-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 511 0 0.00 4 0.00 0.0004
2025-02-06 2024-12-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 511 0 0.00 4 0.00 0.0004
2024-11-01 2024-09-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 511 -77 -13.10 4 33.33 0.0004
2024-07-31 2024-06-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 588 77 15.07 4 0.00 0.0004
2024-04-25 2024-03-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 511 9 1.79 3 0.00 0.0003
2024-02-01 2023-12-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 502 0 0.00 3 50.00 0.0003
2023-10-25 2023-09-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 502 0 0.00 2 100.00 0.0002
2023-07-31 2023-06-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 502 502 2 0.0002
2023-04-26 2023-03-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 0 -78 -100.00 0 0.0000
2023-01-25 2022-12-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 78 -33 -29.73 0 0.0000
2022-11-10 2022-09-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 111 -592 -84.21 0 -100.00
2022-08-01 2022-06-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 703 539 328.66 2 100.00 0.0003
2022-04-21 2022-03-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 164 0 0.00 1 0.00 0.0002
2022-01-18 2021-12-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 164 -262 -61.50 1 -50.00 0.0002
2021-11-05 2021-09-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 426 0 0.00 2 0.00 0.0005
2021-07-27 2021-06-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 426 0 0.00 2 -33.33 0.0004
2021-04-28 2021-03-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 426 0 0.00 3 50.00 0.0007
2021-01-27 2020-12-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 426 0 0.00 2 0.00 0.0005
2020-11-03 2020-09-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 426 0 0.00 2 0.00 0.0006
2020-07-27 2020-06-30 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 426 0 0.00 2 100.00 0.0006
2020-04-22 2020-03-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 426 262 159.76 1 0.00 0.0004
2020-01-27 2019-12-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 164 164 1 0.0003
2019-02-07 2018-12-31 13F AMNEAL PHARMACEUTICALS INC COM STK CL A Stock 03168L105 0 0 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.